Skip to Content
Merck
  • In Silico characterization of phosphorylase kinase: evidence for an alternate intronic polyadenylation site in PHKG1.

In Silico characterization of phosphorylase kinase: evidence for an alternate intronic polyadenylation site in PHKG1.

Molecular genetics and metabolism (2007-08-19)
Joni S Winchester, Eric C Rouchka, Naomi S Rowland, Nancy A Rice
ABSTRACT

Phosphorylase kinase (PhK), the key enzyme that regulates glycogenolysis, has traditionally been thought to be expressed predominantly in muscle and liver. In this study, we show by two different database searches (Expressed Sequence Tag and UniGene) that PhK gene expression occurs in at least 28-36 different tissues, and that the genes encoding the alpha, beta, and gamma subunits of PhK undergo extensive transcriptional processing. In particular, we have identified exon 6 of PHKG1 as a 3' composite terminal exon due to the presence of a weak polyadenylation and cleavage site in intron 6. We have verified biochemically that transcriptional processing of PHKG1 does occur in vivo; mRNA corresponding to the alternate variant is expressed in skeletal muscle, brain, heart, and tongue. In silico translation of this mRNA yields a PhK gamma subunit that contains the first 181 residues of the protein, followed by an additional 21 amino acids. The implication of this alternate processing is discussed within the context of gamma catalysis and regulation.